dihexa safety concerns hgf c-met cancer risk Frontiers Developing c-MET pathway inhibitors for
Developing c MET pathway inhibitors for cancer therapy: progress and challenges: Trends in Molecular Medicine Dihexa (PNB 0408) c Met HGFR Activator MedChemExpress What is dihexa, its mechanism of action via the HGF c Met pathway, and its safety and clinical use? c Met Signaling as a Therapeutic Target in Head : The Cancer Journal Combination of HGF MET targeting agents and other therapeutic strategies in cancer ScienceDirect Frontiers The Function of the HGF c Met Axis in Hepatocellular Carcinoma
Pay in 4 interest-free payments of $6.96 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 30 - Aug 4



